 - Initiation of pimecrolimus cream 1 or greater or tacrolimus ointment 0.03 or greater during the study period or planned dose escalation during the study period. However, initiation of these creamsointments 30 days or more prior to screening and use of a stable maintenance dose during the study period may be considered for inclusion. 